'Moderna Of China' Gets $700m Injection As Investors Bet Big On Domestic mRNA Vaccines

Meteoric Rise For Abogen

 
• By Brian Yang
  
SUZHOU-BASED ABOGEN GETS $700M TO PROGRESS ITS mRNA VACCINES AND THERAPEUTICS • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia